Extremes of body mass index do not impact mid-term survival after continuous-flow left ventricular assist device implantation
Robert J. Brewer(Henry Ford Hospital), Mark S. Slaughter(University of Louisville), David J. Farrar(Southwestern Medical Center), Kartik S. Sundareswaran(Thoratec Corporation (United States)), Chittoor Sai‐Sudhakar(The Ohio State University), Y. Ravi(The Ohio State University), David E. Lanfear(Henry Ford Health System)
Cited by 60
Related Papers
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711
Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
|Circulation|2012|655
Continuous Flow Left Ventricular Assist Device Improves Functional Capacity and Quality of Life of Advanced Heart Failure Patients
|Journal of the American College of Cardiology|2010|583